Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nath Biogene India Ltd. Call Transcript 2023

Apr 25, 2023

63545_rns_2023-04-25_e41ffaa9-8614-42f9-8243-d566baf2183c.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [188 x 86] intentionally omitted <==

25[th ] April 2023

The Manager-Listing The Manager-Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051

BSE Code-537291 NSE Code-NATHBIOGEN

Dear Sir/Madam,

Subject- Audio Transcript of Con Call held on 24[th] April 2023.

Dear Sir’s,

This is with reference to our intimation for Earnings call dated 19[th] April 2023, the audio recording of call with Investors/Analysts can be accessed at, https://nathbiogenes.com/wp-content/uploads/2023/04/Q4FY23-Concall-audio9.mp3

This is for your information and record purpose.

Thanking You

For Nath Bio-Genes (India) Limited

Devinder Gurusharan Khurana Digitally signed by Devinder Gurusharan Khurana DN: c=IN, o=Personal, title=9397, pseudonym=dd37abd9ee3d49159ab4cf27ab5df396, 2.5.4.20=96444f902a1978c28d276b20b641db04cd8e45ee12313d67609b4e6fe19bd322, postalCode=431005, st=Maharashtra, serialNumber=7cc1b5bc4fc61f4fd5a2419f096d29ab52ed0b7c20323e1cbc153f9a24fb995b, cn=Devinder Gurusharan Khurana Date: 2023.04.25 15:31:27 +05'30'

Devinder Khurana Chief Financial Officer

==> picture [452 x 36] intentionally omitted <==